Sei sulla pagina 1di 1

11111

Kaptin
Antidiarrheal
Suspension

0312015

elevated temperature. in such case an antibiotic therapy may be required.

pharmacia

Caution is required in patients suffering from dehydration


antidiarrheaJs may mask its extent.

as adsorben

Consult the doctor if diarrhea is not controlled in 48 hours or if fever developed.


Pregnancy and lactation:This medicine is considered safe as it is not absorbed
into the body and is not likely to cause problems.

Composition
Each 15ml (tablespoonful) contains:
Active ingredients: Light kaolin
2.9g
Pectin
65mg
Excipients:
Sodium citrate. carboxymethylcellulose. glycerol. benzoic
acid. propylene glycol. tween 80. ethanol. anethole. saccharin sodium. and purified water.
Properties
Kaptin suspension is an adsorbent antidiarrheal that is composed of light kaolin
and pectin. Kaolin is a natural hydrated aluminium silicate that is believed to
adsorb large numbers of bacteria and toxins. and to reduce water loss. Pectin is
a polyuronic polymer that consists of purified carbohydrate extracted from citrus
fruit or apple pomace but its mechanism of action is still unknown. S dies have
shown no decrease in stool frequency or fecal weight and water content wi
is
preparation even though stools appeared more formed.
-

This preparation is not absorbed and up to 90% of pectin is decomposed in the


gastrointestinal tract.

Indications
Kaptin is indicated for the symptomatic treatment of mild to moderately acute
diarrhea. It is recommended also for the temporary symptomatic treatment of
chronic diarrhea until the etiology is determined.

Side Effects
No serious Side effects have been reported with the use of Kaptin. However.
mild and transient constipation may occur in some patients specially those who
take a 10 of .
Drug Interac 0 s
When ta en age er, Kaplin may possibly reduce the absorption of aspirin.
chloroquine. hydroxychloroquine. phenothiazines. quinidine. digoxin. lincomycin.
clindamycin. and tetracyclines. It is recommended that Kaptin be administered
not less than 2 hours before or 3 to 4 hours after lincomycin and clindamycin.
Patients receiving digoxin should be monitored closely for evidence of altered
effect.
If you are taking any other medicine. do not take it within 2 to 3 hours of taking
Kaptin. Concurrent administration may prevent the other medicine from being
absorbed by your body.
Presenta 10
Kaptin s spe -

: Bottle of 200mL.

pharmacia

Store at a e oera ure of 15 - 25C.


THIS IS A MEDICAMENT

Dosage
Dose is to be taken after each loose bowel move men
Adults: 60 - 120ml (4 - 8 tablespoonfuls)
Children
12years of age and over: 45 - 60ml (3 - 4 tablespoonfuls
6 - 12years of age: 30 - 60ml (2 - 4 tablespoonfuls)
3 - 6 years of age: 15 - 30ml (1 - 2 tablespoonfuls)
Up to 3 years of age: Use is not recommended un ess rected by a physician

pharmacia

Contraindications
This preparation should be avoided by pa ients who are ypersensitive to
kaolin or pectin. as well as in pa ients suffering from diarrhea secondary to
pseudomembranous enterocolitis or to toxigenic bacteria.
Precautions
This preparation is better to be avoided in suspected parasite-associated diarrhea
as it may make the recognition of the parasitic causes more difficult. In addition.
it is better to be avoided in acute dysentery characterized by bloody stools and

pharmacia

'edcament
is a product which affects your health,
a~d Its consumption
contrary
to instructions
is
dangerous for you.
Follow strictly the doctor's prescription,
the method
of use and the instructions of the pharmacist who sold
the medicament.
The doctor and the pharmacist
are experts in
medicines, their benefits and risks.
Do not by yourself interrupl the period of treatment
prescribed for you.
Do not repeat the same prescription without consulting
your doctor.
Keep all medicaments out of the reach of children.

pharmacia

Council of Arab Health Ministers,


Union of Arab Pharmacists.

Any information? Call Our Toll Free No. (971) 800-4994

.f

-ffj}
1iJh r

Produced by: Julphar


~
Gulf Phannaceutical Industries. ~-:
Ras AI Khairnah, U.A.E.

17/04/2004

Potrebbero piacerti anche